15 May 2006

http://mtbeurope.info/news/2006/605024.htm

Neuroscience Therapy Corp. (OTC: NPYC) has received FDA approval to
begin marketing its electronic pain relief device the P-Stim in the United
States.

P-Stim, which the company claims has been highly successful in treating
pain in thousands of patients in Europe, is now permitted to be
marketed in the U.S. It is a miniaturized electro-stimulation device that
is placed behind the ear with adhesive. It transmits low frequency
electrical pulses via acupuncture-like needles inserted into the ear
muscles. The electrical stimulation releases endorphins, which have an
analgesic effect. The P-Stim can give continuous pain therapy over
several days.

It was stated by the National Institute of Health: "Pain is a critical
national health problem. It is the most common reason for medical
appointments, nearly 40 million visits annually, and costs this country
over $100 billion each year in health care and lost productivity."
Neuroscience Therapy is now able to enter the multi-billion dollar
market for pain releif in the U.S. and plans to begin a nationwide
campaign to promote P-Stim.

President and CEO Dr. Randolph A. Turpin of Neuroscience Therapy
said: "I'm very proud of our team for enabling Neuroscience Therapy to
get to this point. We are now in an ideal position to begin making
revenues in this multi-billion dollar market." The company claims that its
product has no known side effects, unlike many pharmaceutical pain
relievers.